Greenwich LifeSciences, Inc.
NASDAQ:GLSI
12.88 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 |
| Gross Profit
| 0 | -0.001 | -0.001 | 0.005 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.833 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.292 | 2.308 | 2.195 | 2.333 | 2.158 | 1.38 | 1.828 | 2.458 | 1.723 | 0.633 | 1.661 | 2.064 | 0.657 | 0.557 | 0.282 | 0.599 | 0.158 | 0.151 | 0.15 | 0.259 | 0.285 | 1.937 | 0.126 | 1.161 |
| General & Administrative Expenses
| 0.437 | 0.354 | 0.343 | 0.503 | 0.345 | 0.368 | 0.413 | 0.437 | 0.66 | 0.14 | 0.328 | 0.313 | 0.21 | 0.197 | 0.319 | 0.553 | 0.099 | 0.06 | 0.095 | 0.078 | 0.052 | 0.667 | 0.022 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | -0.001 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.437 | 0.354 | 0.342 | 0.502 | 0.345 | 0.368 | 0.413 | 0.437 | 0.66 | 0.14 | 0.328 | 0.313 | 0.21 | 0.197 | 0.319 | 0.553 | 0.099 | 0.06 | 0.095 | 0.078 | 0.052 | 0.667 | 0.022 | 0.394 |
| Other Expenses
| 0 | 0 | 2.195 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2.729 | 2.661 | 2.536 | 2.835 | 2.503 | 1.748 | 2.241 | 2.895 | 2.383 | 0.773 | 1.989 | 2.377 | 0.867 | 0.753 | 0.601 | 1.152 | 0.257 | 0.21 | 0.245 | 0.337 | 0.336 | 2.604 | 0.149 | 1.555 |
| Operating Income
| -2.729 | -2.661 | -2.537 | -2.836 | -2.503 | -1.748 | -2.241 | -2.895 | -2.383 | -0.773 | -1.989 | -2.377 | -0.867 | -0.753 | -0.601 | -1.152 | -0.257 | -0.21 | -0.245 | -0.337 | -0.336 | -2.604 | -0.149 | -1.556 |
| Operating Income Ratio
| 0 | 0 | 0 | -523.446 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.06 | 0.055 | 0.064 | 0.089 | 0.111 | 0.119 | 0.116 | 0.104 | 0.064 | 0.027 | 0.02 | 0.017 | 0.004 | 0.004 | 0.004 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -2.669 | -2.607 | -2.473 | -2.747 | -2.392 | -1.628 | -2.125 | -2.791 | -2.319 | -0.746 | -1.97 | -2.361 | -0.863 | -0.75 | -0.597 | -1.151 | -0.257 | -0.21 | -0.245 | -0.337 | -0.336 | -2.604 | -0.149 | -1.556 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -506.965 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -2.538 | -0 | 0.04 | -0.121 | -0.116 | -0.151 | -0.064 | -0.027 | -0.02 | 0 | 0 | 0 | 0 | -0.712 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 |
| Net Income
| -2.669 | -2.607 | -2.473 | -2.747 | -2.392 | -1.628 | -2.009 | -2.64 | -2.255 | -0.719 | -1.95 | -2.361 | -0.863 | -0.75 | -0.597 | -1.151 | -0.257 | -0.21 | -0.245 | -0.337 | -0.336 | -2.604 | -0.149 | -1.556 |
| Net Income Ratio
| 0 | 0 | 0 | -506.965 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.2 | -0.2 | -0.19 | -0.21 | -0.19 | -0.13 | -0.16 | -0.21 | -0.18 | -0.056 | -0.15 | -0.18 | -0.067 | -0.058 | -0.047 | -0.13 | -0.022 | -0.018 | -0.02 | -0.028 | -0.028 | -0.22 | -0.74 | -0.13 |
| EPS Diluted
| -0.2 | -0.2 | -0.19 | -0.21 | -0.19 | -0.13 | -0.16 | -0.21 | -0.18 | -0.056 | -0.15 | -0.18 | -0.067 | -0.058 | -0.047 | -0.13 | -0.022 | -0.018 | -0.02 | -0.028 | -0.028 | -0.22 | -0.73 | -0.13 |
| EBITDA
| -2.728 | -2.661 | -2.536 | -2.835 | -2.502 | -1.747 | -2.24 | -2.894 | -2.382 | -0.772 | -1.988 | -2.376 | -0.866 | -0.753 | -0.6 | -1.151 | -0.256 | -0.21 | -0.244 | -0.336 | -0.335 | -2.603 | -0.148 | -1.555 |
| EBITDA Ratio
| 0 | 0 | 0 | -523.28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |